Thomas Schall

Thomas Schall

Net worth: 371 905 $ as of 2026-06-29

66 year
Health Technology
Consumer Services

Profile

Thomas J.
Schall
was the founder of ChemoCentryx, Inc., founded in 1997, where the titles held included Chairman, President & Chief Executive Officer from 2012 to 2022.
The current job is Chairman at Immuneering Corp., starting in 2025.
Former jobs include Scientist at Genentech, Inc., and Principal at DNAX Research, Inc. from 1993 to 1997.
Education includes a doctorate from Stanford University and an undergraduate degree from Northern Illinois University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-10 74,530 ( 0.12% ) 371 905 $ 2026-06-29

Thomas Schall active positions

CompaniesPositionStart
IMMUNEERING CORPORATION Chairman 2025-09-15

Former positions of Thomas Schall

CompaniesPositionEnd
CHEMOCENTRYX, INC. Chief Executive Officer 2022-10-19
DNAX Research, Inc.
Corporate Officer/Principal 1996-12-31
Chief Tech/Sci/R&D Officer -
See the detail of Thomas Schall's experience

Training of Thomas Schall

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

30

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Consumer Services

DNAX Research, Inc.

Health Technology